Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid

Giuseppe De Rosa1, Amélie Bochot, Fabiana Quaglia

  • 1Faculté de Pharmacie, Université Paris-Sud UMR CNRS 8612, Group of Drug targeting and delivery of poorly stable compounds, 5, rue Jean-Baptiste Clément, 92296 Châtenay-Malabry, France.

International Journal of Pharmaceutics
|March 5, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NO-PDT and chemotherapy: spatiotemporal control to achieve therapeutic synergy.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2026
Same author

Corrigendum to Robust micelles formulation to improve systemic corticosteroid therapy in sepsis in multiple healthcare systems [Journal of controlled Release, Vol. 381, 10 May 2025, 113635].

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

A Molecular Hybrid for Double Stepwise Nitric Oxide Photorelease with Double Fluorescence Readout in Living Cells.

Chemical & biomedical imaging·2026
Same author

PEG-lipid structure controls in vitro PEG shedding, surface remodeling, and timing of lipid nanoparticle-mediated silencing.

Journal of colloid and interface science·2026
Same author

Double-coated PLGA nanoparticles with hierarchical surface architecture for CD44-targeted siRNA delivery.

Drug delivery and translational research·2026
Same author

Polyelectrolyte complexation with biofunctionalized multivalent ions: Coarse-grained model and isothermal titration calorimetry experiment.

The Journal of chemical physics·2026

Researchers developed microspheres for controlled release of antisense oligonucleotide targeting Transforming growth factor beta(1). These microspheres effectively encapsulate and slowly release oligonucleotide/polyethylenimine complexes for cellular uptake.

Area of Science:

  • Biomaterials Science
  • Drug Delivery
  • Molecular Biology

Background:

  • Transforming growth factor beta(1) is implicated in various diseases.
  • Antisense oligonucleotides offer targeted gene silencing strategies.
  • Controlled release systems are crucial for effective oligonucleotide delivery.

Purpose of the Study:

  • To design and characterize poly(lactide-co-glycolide) (PLGA) microspheres for the controlled release of an antisense oligonucleotide.
  • To investigate the impact of polyethylenimine (PEI) complexation and N/P ratios on microsphere properties.
  • To evaluate the in vitro release profile and potential for cellular internalization.

Main Methods:

  • Preparation of PLGA microspheres using the multiple emulsion-solvent evaporation technique.

Related Experiment Videos

  • Encapsulation of free antisense oligonucleotide or its solid complexes with PEI at varying N/P ratios.
  • Characterization of microspheres for loading efficiency, morphology, internal distribution, and in vitro release kinetics.
  • Main Results:

    • Microsphere characteristics, including loading, morphology, and oligonucleotide distribution, were influenced by the form of encapsulation (free vs. PEI complex), N/P ratio, and PLGA type.
    • The designed microspheres demonstrated successful encapsulation of oligonucleotide/PEI solid complexes.
    • A slow and controlled in vitro release of the encapsulated oligonucleotide/PEI complexes was observed.

    Conclusions:

    • PLGA microspheres effectively encapsulate antisense oligonucleotide/PEI complexes.
    • The formulation parameters (complexation, N/P ratio, PLGA type) significantly influence microsphere performance.
    • The developed microspheres facilitate the slow release of complexes, promoting potential cellular internalization for therapeutic applications.